- 11/13/2025Notice Concerning Disposal of Treasury Shares Through Third-party Allotment Associated with Additional Contribution to the BBT and the J-ESOP
- 11/13/2025CONSOLIDATED FINANCIAL SUMMARY 2Q FY 2025 (from April 1, 2025 to September 30, 2025)
- 11/13/2025Financial results Presentation For the 6-month Period Ended September 30, 2025
- 11/13/2025Notice of Revision of the Financial Results Forecast,Payment of a Dividend of Surplus (Interim Dividend), and Revision of the Dividend Forecast
- 11/06/2025The 2025 version of the Integrated Report is now available.
- 11/05/2025Entering a New Stage in Dementia Prevention - A New Series Under Resorttrust's Nursing Home Brand- "HIMEDIC RESIDENCE THE GARDEN" Opens its Doors
- 10/22/2025Preventive healthcare Pioneer “HIMEDIC” Takes on a New Challenge. Aiming to Achieve “zero-level prevention” that eliminate the causes of cause of disease. Launch of Sales for “HIMEDIC Yokohama Bay Course”
- 10/21/2025Announcement Concerning the Presentation of Results from the Domestic Phase II Clinical Trial at ESMO Congress 2025
- 10/01/2025Announcement of Completion of the Specified Clinical Research of BNCT for Recurrent Breast Cancer, with the Cooperation of CICS (Consolidated Subsidiary of Resorttrust)
- 08/13/2025CONSOLIDATED FINANCIAL SUMMARY 1Q FY 2025 (from April 1, 2025 to June 30, 2025)
- 08/13/2025Financial results Presentation For the 3-month Period Ended June 30, 2025
- 07/28/2025CICS, Inc. (a consolidated subsidiary of Resorttrust, Inc.) has achieved the primary endpoint in a domestic phase II clinical trial of BNCT (Boron Neutron Capture Therapy) for the treatment of angiosarcoma
